Your browser doesn't support javascript.
loading
The Leishmaniasis East Africa Platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis.
Wasunna, Monique; Musa, Ahmed; Hailu, Asrat; Khalil, Eltahir A G; Olobo, Joseph; Juma, Rashid; Wells, Susan; Alvar, Jorge; Balasegaram, Manica.
Afiliação
  • Wasunna M; Drugs for Neglected Diseases initiative, KNH 00202, Nairobi, Kenya Centre for Clinical Research, Kenya Medical Research Institute, KNH 00202, Nairobi, Kenya africa@dndi.org.
  • Musa A; Institute of Endemic Diseases, University of Khartoum, Khartoum 11111, Sudan.
  • Hailu A; Addis Ababa University, Addis Ababa 1000, Ethiopia.
  • Khalil EA; Institute of Endemic Diseases, University of Khartoum, Khartoum 11111, Sudan.
  • Olobo J; Makerere University, Kampala, Uganda.
  • Juma R; Centre for Clinical Research, Kenya Medical Research Institute, KNH 00202, Nairobi, Kenya.
  • Wells S; Drugs for Neglected Diseases initiative, Geneva CH1202, Switzerland.
  • Alvar J; Drugs for Neglected Diseases initiative, Geneva CH1202, Switzerland.
  • Balasegaram M; Drugs for Neglected Diseases initiative, Geneva CH1202, Switzerland.
Trans R Soc Trop Med Hyg ; 110(6): 321-3, 2016 06.
Article em En | MEDLINE | ID: mdl-27268714

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paromomicina / Gluconato de Antimônio e Sódio / Comportamento Cooperativo / Pesquisa Biomédica / Fortalecimento Institucional / Leishmaniose Visceral / Antiprotozoários Tipo de estudo: Guideline Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paromomicina / Gluconato de Antimônio e Sódio / Comportamento Cooperativo / Pesquisa Biomédica / Fortalecimento Institucional / Leishmaniose Visceral / Antiprotozoários Tipo de estudo: Guideline Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2016 Tipo de documento: Article